• Home  ›
• About us  ›
• Executive Management Committee

Dr Nick Ash Managing Director
Dr Ash joined Source BioScience during 2005 and was previously Chief Financial Officer before taking up his current role in February 2007.  Nick oversaw the disposal of the Group's Dubai operations in 2006 and refocused the Group's activities in the UK.  He has led the growth and development of the Group, acquiring the technologies and expertise necessary for the Group's current and planned range of activities, creating a profitable and cash generative business.  Nick is a Chartered Accountant and holds a PhD in Mycology.  Prior to joining Source Bioscience, he was Finance Director at Eastern Airways and spent nine years with KPMG. 

Dr Nick Leaves Operations Director
Dr Leaves is the Operations Director having joined the Company in July 2007, subsequently becoming a Board member in June 2008.  Nick was a co-founder of Geneservice Limited in 2005 via a management buyout of the company from the Medical Research Council.  Prior to this, Nick worked for over ten years in complex genetics and genomics; first for Oxford University on asthma and eczema gene-hunting projects and then for the Medical Research Council in Cambridge on the mouse genome project.  Nick originally qualified as a microbiologist and worked in the NHS completing a PhD in 1995 on the molecular methods used to characterise outbreaks of bacterial meningitis. 

Eileen Barrett Head of Legal and Employment
Ms Barrett joined the Company in 2001 as a cofounder of Pathlore Limited now Source BioScience UK Limited, a wholly owned subsidiary of Source BioScience plc. Eileen graduated from Sheffield University with a BSc Hons in Genetics and spent a year as a trainee accountant before undertaking a PGCE and qualifying as a teacher. She taught Physics for 13 years eventually becoming acting Head of Physics at the German Swiss International School in Hong Kong. Whilst teaching, Eileen undertook a conversion to Law at Hong Kong University and returned to the UK in 1994 to complete the LPC at Nottingham Law School. Following law school Eileen worked for the Brussels based Federation of European Cancer Societies leading the construction of a pan European Medical Education Project, which won European Commission funding in 1999.

Roger Coombes Head of Healthcare
Mr Coombes joined the Company in November 2002 as Commercial Director and was appointed Director, Cytology in July 2004. With the acquisition of Geneservice in July 2007 he was appointed Head of Healthcare. Roger previously worked in the pharmaceutical industry for a number of companies including Pfizer, Rhone Poulenc and, for 25 years, the pharmaceutical Division of Boots where he held various senior UK marketing positions before being seconded to their M&A Group. He was for a time Managing Director of Boots GmbH based in Germany, Director of Business Development in Nottingham and finally Boots Export Director based in Nottingham. He joined BASF, when Boots Pharmaceuticals was sold to that company, and was appointed Director, International Pain Management Group. Roger has a BSc in Biochemistry (London) and a Diploma in Marketing.

Professor Ian Ellis Medical Director (and Professor of Cancer Pathology Nottingham University, Honorary Consultant Pathologist Nottingham City Hospital)
Professor Ellis is the Company's Medical Director and was a cofounder of Pathlore Limited now Source BioScience UK Limited, a wholly owned subsidiary of Source BioScience plc. He is an experienced diagnostic histopathologist with an international reputation in diagnosis and translational research in breast disease, particularly classification of breast cancer and evaluation of prognostic factors. He has authored over 300 scientific publications, chapters in medical textbooks and specialist textbooks in pathology and is an experienced lecturer. He is a Specialty Advisor of The Royal College of Pathologists, Chairman of the UK National Co-coordinating Committee for Breast Pathology, Steering Committee Member of The European Group for Breast Screening Pathology and President of the International Society of Breast Pathology. He has acted as an advisor to the Department of Health, International Union against Cancer, World Health Organisation and International Agency for Research on Cancer.

Dr Cliff Murray Head of Research & Development
Dr Murray joined the Company in January 2005. Prior to that, he was Reader in Oncology at Nottingham University and Director of the CRUK Tumour Cytokine Biology Group since 1994. The interests of his group included tumour angiogenesis and novel mechanisms employed by tumours to evade the host immune response. Cliff has a BSc in Biochemistry from St. Andrews, and a PhD in Pathology and Biochemistry from Cambridge.

Simon Palmer Head of Client Relations and Contract Management
Mr Palmer joined the Company in October 2002 during which time he has undertaken the roles of Project Manager, Projects & Data Manager, Head of Operations and most recently Head of Client Relations and Contract Management. Prior to this, Simon worked for over 15 years within the health informatics field, principally within primary and secondary care, including 8 years as the Development Manager for a Nottingham-based software house developing integrated clinical information systems for women's and children's health. Simon has an MSc in Health Information Management from the University of Wales (Aberystwyth).